The traditional vacuum activation of covalent organic framework (COF) materials typically erodes the materials' crystallinity significantly and then reduces the surface area of isolated materials. Developing new methods for synthesizing robust COFs which could survive the duration of the vacuum activation process is of great practical significance. In this work, a robust imine-linked 2D COF TAPB-TA was creatively constructed in supercritical CO 2 (ScCO 2 ) with γ-valerolactone (GVL) as a cosolvent instead of previously widely reported reaction conditions. Upon vacuum activation, the as-prepared COF (denoted as Sc-COF) via this green synthesis could still possess a high surface area, while preventing the pores from undesirable collapse and the loss of material quality could be avoided successfully. Further, Sc-COF showed excellent stability toward solvent immersion−reactivation cycles. Furthermore, this method is universal and can be facilely extended to the synthesis of other iminelinked 2D COFs and is expected to be transferable to a broader range of customized COFs. Theoretic calculations imply that ScCO 2 serves to attenuate the COF−COF interactions during the activation process preventing the collapse of the structure. It decreases the viscosity of the solution as compared to pure GVL, enabling fast diffusion kinetics of monomers to the reactive sites. Moreover, thanks to the low dielectric constant, usage of the ScCO 2 solvent diminishes the energy barriers of imine bond formation, thus facilitating ordered COF growth. These insights have important implications for studying and understanding how more robust 2D COFs could form and thus greatly expand their practical applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.